The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases

被引：24

作者：

Hu, LY ^{[1
]}

Boxer, PA ^{[1
]}

Kesten, SR ^{[1
]}

Lei, HSJ ^{[1
]}

Wustrow, DJ ^{[1
]}

Moreland, DW ^{[1
]}

Zhang, LM ^{[1
]}

Ahn, K ^{[1
]}

Ryder, TR ^{[1
]}

Liu, XH ^{[1
]}

Rubin, JR ^{[1
]}

Fahnoe, K ^{[1
]}

Carroll, RT ^{[1
]}

Dutta, S ^{[1
]}

Fahnoe, DC ^{[1
]}

Probert, AW ^{[1
]}

Roof, RL ^{[1
]}

Rafferty, MF ^{[1
]}

Kostlan, CR ^{[1
]}

Scholten, JD ^{[1
]}

Hood, M ^{[1
]}

Ren, XD ^{[1
]}

Schielke, GP ^{[1
]}

Su, TZ ^{[1
]}

Taylor, CP ^{[1
]}

Mistry, A ^{[1
]}

McConnell, P ^{[1
]}

Hasemann, C ^{[1
]}

Ohren, J ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Ann Arbor, MI USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 09期

关键词：

D O I：

10.1016/j.bmcl.2005.07.058

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The inhibition of the cytosolic isoenzyme BCAT that is expressed specifically in neuronal tissue is likely to be useful for the treatment of neurodegenerative and other neurological disorders where glutamatergic mechanisms are implicated. Compound 2 exhibited an IC50 of 0.8 mu M in the hBCATc assays; it is an active and selective inhibitor. Inhibitor 2 also blocked calcium influx into neuronal cells following inhibition of glutamate uptake, and demonstrated neuroprotective efficacy in vivo. SAR, pharmacology, and the crystal structure of hBCATc with inhibitor 2 are described. (C) 2005 Elsevier Ltd. All rights reserved.

引用

页码：2337 / 2340

页数：4

共 50 条

[21] BRANCHED-CHAIN AMINO-ACID AMINOTRANSFERASE ISOENZYMES OF PSEUDOMONAS-CEPACIA
WONG, HC
LESSIE, TG
ARCHIVES OF MICROBIOLOGY, 1979, 120 (03) : 223 - 229
[22] BRANCHED-CHAIN AMINO-ACID AMINOTRANSFERASE ALONG THE RABBIT AND RAT NEPHRON
BURCH, HB
CAMBON, N
LOWRY, OH
KIDNEY INTERNATIONAL, 1985, 28 (02) : 114 - 117
[23] N-TERMINAL SEQUENCE OF BRANCHED-CHAIN AMINO-ACID AMINOTRANSFERASE
RANDALL, RR
WALLIS, MH
YOUNG, GJ
ARMSTRONG, FB
FEDERATION PROCEEDINGS, 1979, 38 (03) : 325 - 325
[24] The structure of human mitochondrial branched-chain aminotransferase
Yennawar, N
Dunbar, J
Conway, M
Hutson, S
Farber, G
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2001, 57 : 506 - 515
[25] Genes encoding for branched-chain amino acid aminotransferase are differentially expressed in plants
Campbell, MA
Patel, JK
Meyers, JL
Myrick, LC
Gustin, JL
PLANT PHYSIOLOGY AND BIOCHEMISTRY, 2001, 39 (10) : 855 - 860
[26] CRYSTALLOGRAPHIC STUDY OF BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE FROM ESCHERICHIA COLI
Okada, Kengo
Hirotsu, Ken
Hayashi, Hidoyuki
Kagamiyama, Hiroyuki
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C113 - C113
[27] AMINO-ACID SEQUENCE OF SALMONELLA-TYPHIMURIUM BRANCHED-CHAIN AMINO-ACID AMINOTRANSFERASE
FIELD, MJ
NGUYEN, DC
ARMSTRONG, FB
BIOCHEMISTRY, 1989, 28 (12) : 5306 - 5310
[28] The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
Dimou, Aikaterini
Tsimihodimos, Vasilis
Bairaktari, Eleni
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[29] A STUDY OF BRANCHED-CHAIN AMINO-ACID AMINOTRANSFERASE AND ISOLATION OF MUTATIONS AFFECTING THE CATABOLISM OF BRANCHED-CHAIN AMINO-ACIDS IN SACCHAROMYCES-CEREVISIAE
DICKINSON, JR
NORTE, V
FEBS LETTERS, 1993, 326 (1-3) : 29 - 32
[30] Docking and quantitative structure-activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase
Caballero, Julio
Vergara-Jaque, Ariela
Fernandez, Michael
Coll, Deysma
MOLECULAR DIVERSITY, 2009, 13 (04) : 493 - 500

← 1 2 3 4 5 →